Anemocyte is excited to announce its participation as an exhibitor at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, taking place from May 7 to 10 in New Orleans, Louisiana. As a leading Biotech Manufacturing Organization (BMO), Anemocyte is at the forefront of delivering advanced manufacturing solutions that accelerate the development of cell and gene therapies.
ISCT 2025 is set to convene over 2,700 global delegates, including scientists, clinicians, regulatory experts, and industry leaders, to discuss the latest advancements in cell and gene therapy. The conference will feature more than 50 roundtable sessions on pivotal topics such as induced pluripotent stem cells (iPSCs), exosomes, CAR-T therapies, artificial intelligence, bio-manufacturing, and regulatory harmonization.
Key Highlights of ISCT 2025: innovation and opportunities
- Translational Pathway Program: engage with thought leaders presenting groundbreaking research across all stages of product development, from early discovery to innovative approaches enhancing access to cell and gene therapies.
- Innovation Zone: discover disruptive technologies from early-stage companies aiming to revolutionize the cell and gene therapy landscape.
- Global Showcase Presentations: attend fast-paced sessions where companies highlight their latest products and technological advancements.
- Networking Opportunities: participate in events like the ISCT Presidential Welcome Reception, Poster Networking Receptions, and the ISCT Gala Celebration, offering ample opportunities to connect with peers and industry experts.
Anemocyte’s booth at the International Society for Cell & Gene Therapy
Anemocyte’s presence at ISCT 2025 underscores its commitment to driving innovation in cell and gene therapy manufacturing.
Attendees are invited to visit Anemocyte’s booth to learn more about its cutting-edge solutions and discuss potential collaborations.
For more information about ISCT 2025 and to register for the event, please visit the official ISCT 2025 website.
